Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Journal editors could help raise profile of three Rs of animal research
EDITOR The human race has a moral imperative to reduce the pain, suffering,
and distress that it inflicts on other animals to an absolute minimum.
In the case of animal experiments, the principle of the three
Rs One way to raise the profile of the three Rs, and push for them to
pervade the whole of the life sciences, would be for journal editors to
insist that published papers include comprehensive information about
the lifetime experiences of the animals involved. This could include
their source, transport, husbandry and care, group sizes and structure,
enrichment, what was actually done to the animals, protocol
refinements, welfare problems (and what was done about them), and the
animals' eventual fate (and why).
Journal space is at a premium, but it is possible to convey this
information in surprisingly few words.
2 3
Such detail would provide guidance for other researchers wishing to improve animal
welfare and reduce suffering, as well as giving other interested parties an insight into what laboratory animals actually experience and
why. This would help to depolarise the debate and enable people with an
interest to contribute to it in an informed and constructive way.
Although the BMJ rarely publishes animal research, perhaps
it would consider this kind of comprehensive editorial policy to help
steer the debate towards the middle ground so that it can go further, faster.
The RSPCA (Royal Society for the Protection of Cruelty to
Animals) believes that the use of laboratory animals presents an
ethical dilemma that affects everyone. Animals are used for a broad
range of purposes, and thus it is not possible or constructive to make
sweeping statements about scientific validity, justification, or
suffering. Issues subject to such polarised debate are inevitably difficult to resolve. In this case, sentient animals capable of suffering are involved.
replacement, reduction, refinement1
is an excellent practical starting point, and the RSPCA is committed to promoting and
supporting it. Greater consideration is now given to implementing this
concept, but it is not universally applied (or understood), and much is
still to be achieved. One likely reason for this is that the three Rs
are often seen as a separate issue and not part of mainstream life sciences.
Research Animals Department, RSPCA, Horsham, West Sussex HH13
7WN Research_Animals{at}rspca.org.uk
| 1. |
Smith R.
Animal research: the need for a middle ground.
BMJ
2001;
322:
248-249 |
| 2. | Morton DB. A fair press for animals. New Scientist 1992; 1816: 28-30. |
| 3. | Smith JA, Birke L, Sadler D. Reporting animal use in scientific papers. Lab Anim 1997; 31: 312-317[CrossRef][Medline]. |
Ethics committees have influenced animal experiments in Sweden
EDITOR In Sweden the review of animal experimentation by animal ethics
committees was made compulsory in July 1979. Until 1998 the decisions
of the seven regional committees were advisory; after that date they
became regulatory. Scientists may, if their application is rejected,
appeal to a higher court.
The debate in the United Kingdom on animal
research1 and the impending Home Office review of the
system2 prompted us to scrutinise the influence that
ethics committees have had on animal experimentation in Sweden.
We analysed whether and how the committees have approved the applications subject to minor changes. We explored the main reasons for these conditions and how their frequency varied over time by analysing protocols from the meetings of three ethics committees (Jan 1989-Sept 2000). Altogether 10 432 applications were processed: 7895 were approved, 1907 were approved with modifications, 427 were postponed, 105 were rejected, and the applicants withdrew 98. Some applications required more than one modification before approval. The table shows how the modifications to project applications that were required by the ethics committees before approval may be grouped.
The frequency of modifications required by the ethics committees varied over the years from 10% to 30% (overall average 18%). The three year moving average showed an increasing trend from 16% to 29% during 1999 and 2000. This may reflect a media debate during this period on the ethics committees' role, which was initiated by a government investigation.3
The areas that the ethics committees focused on has varied with time. In recent years pain relief and ensuring the presence of a licensed supervisor seem to have received increasing attention, whereas the interest in introducing earlier humane end points seems to be decreasing.
About three quarters of the modifications may be categorised as
refinement with respect to animal welfare, and the modifications requested have had a positive influence on project designs. The systems
in the United Kingdom and Sweden cannot, however, be directly compared.
The Home Office Inspectorate has played an active and professional part
in the United Kingdom in improving project applications through
dialogue with individual applicants. The introduction of ethics
committees in the United Kingdom might simply result in this important
activity being moved from the inspectorate to being a responsibility of
an ethics committee.
Three Rs should be registration, randomisation, and reviews
(systematic)
EDITOR Some trials are properly randomised but many are not. The potential for
selective publication of trials showing more promising treatment
effects is considerable, and few if any of the trials set their results
in the context of a systematic review of all previous trials. Reducing
bias is as important in animal research as in clinical research, and it
would seem appropriate to apply the strategies used to improve the
quality of clinical research to improve animal research. I therefore
propose the following three Rs of animal research:
Would middle ground approach give "added value"?
EDITOR He admired the university's courage in opening its laboratory doors
and facing frank discussion with "the enemy." He found that the
researchers, far from being the crazed animal torturers of his
imagination, were reasonable and caring. They accepted proposals that
the animal rights group put forward for improvements in the quality of
life of the laboratory animals, and a follow up visit confirmed progress.
Aggression projected on to this animal research laboratory was
unsustainable once a cooperative relationship had been established. When I drew attention to the turnaround in my friend's views he rationalised it by saying, "I haven't changed my mind about animal research. This laboratory is different from the others Was this laboratory different from others? Perhaps it was, because it
invested in communication and contact rather than condemnation and
distance, or perhaps because it took a long and sensitive look at its
activities in relation to the prevailing sentiment in society. A common
pitfall for animal experimentation is that familiarity breeds contempt.
I have encountered very caring doctors, scientists, and vets who became
inured over time to what they were doing to sentient creatures in the
name of medical or veterinary research.
Both sides of the animal research debate regale us with visions of how
good life could be for humans or animals if we would just give them a
free hand. Both sides are willing to torment, maim, and kill, as
required. How many of these visions are fantasies, I wonder? How many
are worth the price that society may have to pay?
We need visions to further our quality of life, including the vision of
living harmoniously with other creatures. Should our society facilitate
all the visions that people seek to promulgate? If not, how can we weed
out those that are about ignorance, personal ambition, projected
emotions, or commercial greed?
All sectors of society have a part to play. I have proposed a model for
such cooperation in the welfare of farm animals that could easily be
extended to medical research (www.pighealth.com).
More funding must go towards finding alternative non-animal
methods
EDITOR British and European law dictates that animals can be used only when no
non-animal alternative is available. The development of reliable
alternative methods is the best way of achieving the fund's ultimate
goal of eliminating the need for live animal experiments.
Current levels of funding for research into alternative methods are
disappointing. If the government wants the decline in the number of
tests on animals to continue then this funding must be dramatically
increased. As well as the government, the industries that currently
rely on animal research to develop and market their products could
support this research into non-animal methods. The Fund for the
Replacement of Animals in Medical Experiments would like to see the
industries putting considerably more of their resources into developing
alternative methods.
The development and validation of non-animal methods is long and
expensive. The rewards, though, are potentially great in terms of the
benefits to science and to animal welfare.
Various fallacies persist in vivisection debate
EDITOR Thalidomide was never tested in pregnant animals before its use in
patients. After the first publication describing fetal abnormalities in
babies whose mothers had taken thalidomide during pregnancy the drug
was shown to be teratogenic in rats, mice, hamsters, rabbits, and three
species of monkeys. The mandatory teratogenic tests on potential
medicines instituted by the regulatory authorities as a result of the
thalidomide disaster prevented a similar tragedy with the oral acne
treatment retinoin. This medicine, because of its efficacy, was
marketed despite its known teratogenicity in laboratory animals. Since
it was labelled as having a confirmed teratogenic risk, only a few
cases of fetal abnormality occurred as a result of inadvertent exposure.
The claim that isoprenaline is well tolerated in cats at doses 175 times greater than those considered safe for humans is also incorrect.
The human data were gathered from patients taking isoprenaline during
the hypoxic conditions of an asthma attack; if cats are rendered
similarly hypoxic they also become sensitive to the cardiotoxic actions
of isoprenaline.
The antivivisection literature is replete with emotive propaganda
and exaggerated claims of "bad science." A definitive examination of the literature, however, generally exposes criticisms as
spurious. Their perpetuation in books such as Vivisection or
Science does nothing for the ethical debate.
Jann Hau
Jann.Hau{at}bmc.uu.se
Hans-Erik Carlsson
Joakim Hagelin
Department of Physiology, Division of Comparative Medicine,
University of Uppsala, BMC Box 572, SE-75123 Uppsala, Sweden
1.
Smith R.
Animal research: the need for a middle ground.
BMJ
2001;
322:
248-249. (3 February.)
2.
UK government reviews animal experiments policy.
Nature
2000;
408:
129.
3.
Djurförsök: Betänkande av 1997 års utredning om alternativa metoder till djurförsök och försöksdjursanvändningens omfattning i framtiden mm. SOU 1998.
Stockholm: Fritzes Offentliga Publikationer, 1998:75.
Having found no reliable evidence from human clinical research
about how much fluid should be given in the resuscitation of bleeding
trauma patients, I am working with others on a systematic review of
controlled trials of fluid replacement in animal models.1 To date we have identified about 70 controlled trials.
Institute of Child Health, London WC1N 1EH
ian.roberts{at}ich.ucl.ac.uk
1.
Roberts I, Evans P, Bunn F, Kwan I, Crowhurst E.
Is the normalisation of blood pressure in bleeding trauma patients harmful?
Lancet
2001;
357:
385-387[CrossRef][Medline].
Forty years ago, before animal rights militancy had driven
animal research behind a wall of secrecy, the University of Manchester
invited an antivivisection group to tour its animal research
laboratories and meet the research scientists. My friend, an animal
rights activist with a highly polarised viewpoint, was determined to
confront these "animal torturers." When he returned he was,
surprisingly, full of praise for the researchers.
it genuinely cares about its animals."
Pig Disease Information Centre, Lolworth, Cambridgeshire CB3
8DS pdic{at}btinternet.com
Throughout the recent, highly emotive debate regarding animal
experimentation and the fate of the medical research firm Huntingdon
Life Sciences1 one crucial factor has been ignored
namely, the importance of non-animal alternative methods. The
Fund for the Replacement of Animals in Medical Experiments (FRAME) is a
charity that funds research into the development of alternative methods
that do not require the use of animals. We were pleased to see Smith's
editorial, which acknowledged the crucial role that alternative methods
can have in bringing about a reduction in the use of animals in
research and testing.2
FRAME (Fund for the Replacement of Animals in Medical
Experiments), Nottingham NG1 4EE sam{at}frame-uk.demon.co.uk
1.
MacDonald R.
How animal passions became aroused.
BMJ
2001;
322:
244 2.
Smith R.
Animal research: the need for a middle ground.
BMJ
2001;
322:
248-249. (3 February.)
MacDonald might not have produced such a favourable review of
Croce's book on the ethics of experimenting on animals had she had the
time and inclination to research his claims that animal research is
scientifically flawed.1
51 Woodbourne Avenue, London SW16 1UX r.botting{at}qmw.ac.uk
1.
MacDonald R.
Vivisection or science? An investigation into testing drugs and safeguarding health [book review].
BMJ
2001;
322:
115
© BMJ 2001
Read all Rapid Responses
What can you learn from this BMJ paper? Read Leanne Tite's Paper+